Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/07/2003EP0804247B1 Selenium conjugates for the preparation of free radical pharmaceuticals
05/07/2003EP0752848B1 Pharmaceutical excipient having improved compressibility
05/07/2003EP0749440B1 Method of isolating and purifying a biomacromolecule
05/07/2003EP0673258B1 Polymer-bound camptothecin derivatives
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416353A Anti-infective active substance combinations and use thereof for topical treatment of fungus diseases of toe and finger nails
05/07/2003CN1416351A HIV immune adjuvant therapy
05/07/2003CN1416341A Stable emulsion compsns
05/07/2003CN1416340A Compsns for delivery of contisol antagonist
05/07/2003CN1416338A Acrylic enteric coating compsns.
05/07/2003CN1416337A Anaesthetic formulations
05/07/2003CN1416336A New self emulsifying drug delivery system
05/07/2003CN1416335A New self emulsifying drug delivery system
05/07/2003CN1416334A 脂质载体 Lipid carrier
05/07/2003CN1416322A Diabetic nutritionals
05/07/2003CN1415716A Grease of ageratum nut and its preparation method and usage
05/07/2003CN1107522C Skin permeation enhancer compsns. using acyl lactylates
05/07/2003CN1107500C Oral rapamycin formulations
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559187 For treating hyperglycemia and diabetes
05/06/2003US6559154 Composition of sodium channel blocking compound
05/06/2003US6559134 Mixture with sugar and, or sugar alcohol
05/06/2003US6559125 Alkylator linked to a polyamide, wherein polyamide comprises at least one pyrrole or imidazole amino acid and wherein polyamide comprises a gamma-aminobutyric acid linked to alkylator; alkylator selectively alkylates one strand of DNA
05/06/2003US6559122 Formulated composition
05/06/2003US6559119 Biomedical device intended for implantation into an animal's body and having a supplemented tissue sealant composition applied to at least a portion of at least one surface thereof
05/06/2003US6558710 Zinc oxide, its hydrated complex with glycine or lycine and free anhydrous glycine; healing skin; minimizing irritation without loss of efficacy
05/06/2003US6558707 Micronized particles in carrier such as a purified, micro-crystalline or alkylated cellulose
05/06/2003US6558706 For use in air fresheners, laundry detergents, fabric softeners, deodorants, lotions
05/06/2003US6558704 Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient
05/06/2003US6558703 Porous hydroxyapatite particles as carriers for drug substances
05/06/2003US6558702 Mixture of polymer and bisphosphonate compound
05/06/2003US6558701 Multilayer tablet for administering a fixed combination of tramadol and diclofenac
05/06/2003US6558696 Desoxypeganine
05/06/2003US6558695 Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
05/06/2003US6558692 Over-coated chewing gum formulations
05/06/2003US6558672 Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/06/2003US6558658 Delivery of poly (ethylene glycol)-modified molecules from degradable hydrogels
05/06/2003CA2267093C Composition comprising a liquid absorbed on a support based on precipitate silica
05/06/2003CA2230131C Topical solid aqueous composition having the appearance of a gel allowing the formation of a film on application
05/06/2003CA2212779C Compositions comprising nanoparticles of nsaid
05/06/2003CA2047802C Pharmaceutical compositions
05/05/2003WO2002036168A1 Cellulosic particle for pharmaceutical preparation
05/02/2003EP1306095A2 Methods and compositions for targeting the vasculature of solid tumors
05/02/2003EP1306087A1 Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient
05/02/2003EP1306083A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
05/02/2003EP1306082A1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations
05/02/2003EP1306076A2 Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions
05/02/2003EP1306072A2 Homogeneous mixtures of silicone oils and organic oils
05/02/2003EP1305378A1 Medical contact adhesive comprising a two phase adhesive matrix of polyacrylates and polyamine salts
05/02/2003EP1305355A1 Hydrogel films and methods of making and using therefor
05/02/2003EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
05/02/2003EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
05/02/2003EP1305322A2 Derivatives of branched-chain lipophilic molecules and uses thereof
05/02/2003EP1305064A1 Bioabsorbable composites of derivatized hyaluronic acid
05/02/2003EP1305057A1 Microparticulate biomaterial composition for medical use
05/02/2003EP1305053A1 A medicinal aerosol formulation
05/02/2003EP1305051A2 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
05/02/2003EP1305050A2 Improved oral dosage formulations
05/02/2003EP1305049A1 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss
05/02/2003EP1305033A1 Pharmaceutical compositions containing tobramycin and xanthan gum
05/02/2003EP1305027A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer
05/02/2003EP1305021A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
05/02/2003EP1305011A1 Compositions and films for capsule manufacture
05/02/2003EP1305010A2 Dosage forms for treatment of oral mycoses
05/02/2003EP1305009A1 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
05/02/2003EP1305008A2 Improved forms of pharmaceutically active agents and method for manufacture thereof
05/02/2003EP1305007A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
05/02/2003EP1305006A2 Dispersions for formulating slightly or poorly soluble active ingredients
05/02/2003EP1305005A2 Microemulsion and micelle systems for solubilizing drugs
05/02/2003EP1304992A1 Topical gel delivery system
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1213972B1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars"
05/02/2003EP1200064B1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip
05/02/2003EP1171111B1 Granulate with high content of l-carnitine or an alkanoyl l-carnitine, particularly suitable for the production of tablets by direct compression
05/02/2003EP1148864B1 Hair treatment compositions comprising c20 or higher unsaturated fatty acid polyester of cyclic polyols
05/02/2003EP1140115B1 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
05/02/2003EP1140061B1 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
05/02/2003EP1093361B1 Plaster which contains steroids, and a method for the production and use thereof
05/02/2003EP1056475B1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors
05/02/2003EP1036167B1 Nuclear targeting by means of streptococcal protein h
05/02/2003EP1028748B1 Compositions providing for increased igf-i solubility
05/02/2003EP1021171B1 Delayed total release gastrointestinal drug delivery system
05/02/2003EP1007014B1 Transdermal, hormone-delivering therapeutic system
05/02/2003EP1003557B1 New salts with beneficial organoleptic properties
05/02/2003EP1001813B1 Pharmaceutical formulations containing voriconazole
05/02/2003EP0998272B1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
05/02/2003EP0983037B1 Antifungal nail lacquer
05/02/2003EP0948544B1 Monovalent antibody fragments
05/02/2003EP0941075B1 Rapidly releasing and taste-masking pharmaceutical dosage form
05/02/2003EP0939771B1 Water soluble lipidated arabinogalactan
05/02/2003EP0874642B1 Sustained release drug formulations
05/02/2003EP0868184B1 Sustained-release microgranules containing diltiazem as the active principle
05/02/2003EP0812187B1 Solid nanoparticulate pharmaceutical composition
05/02/2003EP0805628B1 Receptor specific transepithelial transport of immunogens
05/02/2003EP0801562B1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
05/02/2003EP0712635B1 Medical polymer gel
05/01/2003WO2003035830A2 Efficient synthesis of protein-oligonucleotide conjugates
1 ... 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 ... 1712